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Follicular lymphoma is the most common low-grade lymphoma and it frequently 
presents with a systemic disease, often showing advanced clinical stage (III/IV). The 
lymphoma cells are usually growing associated with follicular dendritic cell (FDC) 
networks. Abnormal FDC networks have been reported in duodenal follicular 
lymphoma, in which cases exhibit lower clinical stages than the nodal cases. In the 
present study, we analyzed the FDC network distribution pattern of 242 nodal follicular 
lymphomas by immunohistochemistry. Out of the 242 cases, 27 cases (11%) 
demonstrated an atypical pattern of FDC networks, in which the CD21 staining totally 
or partially disappeared in the neoplastic follicles. Furthermore, we compared the 
clinical data of these 27 cases and 58 typical FDC network cases of follicular 
lymphoma. We found that in the typical cases, 52 out of 58 patients (90%) showed 
advanced clinical stage (III or IV), whereas 10 of 27 (37%) atypical FDC network cases 
showed localized clinical stage (I or II) (P < 0.01). In conclusion, nodal follicular 
lymphoma with total loss or partially disrupted FDC networks therefore show a lower 
clinical stage. 
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Follicular lymphoma (FL) is a neoplasm composed of follicle center B cells which usually 
shows a follicular pattern.1 The majority of FLs originate from lymph node, and roughly 70% of 
the patients are diagnosed as advanced clinical stages (III or IV). Bone marrow involvement 
is found in up to 50% of the cases. In the majority (70%–95%) of FLs with histological grade 
1, 2, and 3A, a characteristic chromosomal translocation of t(14; 18)(q32; q21) can be 
detected.1–3 
We have reported that FL frequently originates from duodenum,4 and most of them are at 
lower clinical stages than the nodal cases.4,5 Although follicular dendritic cell (FDC) networks 
densely occupied the neoplastic follicle areas in most of the nodal FL, we found that in 
duodenal FL, FDC networks were frequently distributed to the periphery of the neoplastic 
follicles, and its clinical features similar to mucosa-associated lymphoid tissue (MALT) 
lymphoma.6 As a matter of fact, this duodenal-like FDC pattern was occasionally observed in 
a small fraction of cases of nodal FL. 
Considering this finding, we examined the FDC networks patterns in cases of nodal FLs by 
immunostaining for FDC marker, CD21,7 and investigated the clinical data of relevant 
patients, thereby evaluating whether the characteristic distribution of FDC networks related to 
the disease progression. 
MATERIALS AND METHODS 
Case selection and clinical data 
Two hundred and forty-two cases of nodal FL were retrieved from the surgical pathology 
consultation files of the Department of Pathology, Okayama University Graduate School of 
Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan between 1995 and 2009. 
All samples examined in the present study were lymph node biopsy sections. Histological 
sections and immunohistochemistry were reviewed to confirm the diagnosis. The neoplastic 
follicles displayed a CD10 positive and/or Bcl2 positive to distinguish from other low-grade B 
cell lymphoma. Cases of FL grade 3B were not included in the study because these tumors 
may have different biologic behavior.1,8 Clinical data were kindly provided by the referring 
clinicians, or obtained from medical records of patients. All data and samples from patients 
were collected with their informed consent. 
Immunohistochemistry 
All immunohistochemistry was performed on paraffin sections using standard antigen retrieval 
protocols, an automated immunostainer (Ventana Medical System, Tucson, AZ, USA). The 
primary antibodies used were: CD10 (56C6, 1:100, Leica, Newcastle, UK), Bcl2 (3.1, 1:100, 
Leica), Ki-67 (MIB-1, 1:5000; Novocastra, Newcastle, UK) and CD21 (1F8, 1:20; DAKO, 
Glostrup, Denmark).5 
Ki-67 labeling index was evaluated semiquantitatively using the average estimated 
percentage of positive cells in 10 recorded high-power fields. All data and samples from 
patients were collected with their informed consent. 
Statistical analysis 
Differences of clinical stage data between the study groups was tested on their statistical 
significance using Fisher’s exact test. Comparisons among mean values were performed 
using t-test. SPSS version 14.0 (SPSS, Chicago, IL, USA) was used to analyze the data. 
RESULTS 
CD21 expression pattern 
The distribution of FDC networks of 242 cases, which were diagnosed as nodal FL were 
examined by immunohistochemistry, and the staining patterns of FDC expression for CD21 
are shown in Fig. 1. Two hundred and fifteen of 242 (89%) cases showed typical (nodal) FDC 
networks pattern (Fig. 1a), in which the FDC were densely found within neoplastic follicle 
areas. In contrast, the remaining 27 (11%) cases showed several types of atypical FDC 
pattern, which were identified as partial or complete loss of FDC antigen CD21 expression in 
neoplastic follicle areas. According to the characteristic distribution of FDC networks, we 
further divided these 27 cases into three patterns: FDC networks were absent in most of the 
neoplastic follicle areas and was referred to as vanished pattern (17 cases, 63%). FDC 
distributed in the periphery of the neoplastic follicles areas was referred to as duodenal 
pattern (three cases, 11%). And finally, marginal pattern (seven cases, 26%) in which FDC 
meshworks occupied more than half of the neoplastic follicle areas, but were absent in the 
center of the tumor follicles. (Fig. 1b–d) 
Clinical data and statistics analysis 
The study group consisted of 27 cases (16 male, 11 female; age range, 39–84; median, 59.0) 
with an atypical FDC pattern. For control group, clinical data from 58 cases with typical FDC 
pattern were selected based on the available clinical records (34 male, 24 female; age range, 
32–85; average, 58.1). All the clinicopathologic data are summarized in Table 1. There was no 
significant difference in the histological grade between study and control group. 
Clinical stages in the study group of 27 cases with the atypical FDC pattern, were stage I 
(four cases), II (six cases), III (11 cases) and IV (six cases), resulting in a systemic disease 
stage (III or IV) in 17 of 27 cases (63%). In the control group with typical FDC pattern, 90% of 
the patients (52 of 58 cases) suffered from a systemic disease. There were no cases in 
clinical stage I, and only six of 58 cases (10%) showed localized clinical stage II. The 
difference between the study and control group was statistically significant (P < 0.01). We 
further compared the three sub-classified atypical FDC pattern cases with the control group 
separately. Interestingly, the vanished and duodenal FDC pattern cases showed a high rate of 
localized clinical stage (P < 0.05), but there was no statistically significant difference in the 
cases with marginal FDC pattern (Table 2). 
Ki-67 labeling index 
Cases with histological grade 1 were selected from the study group (16 cases) and the 
control group (30 cases) for immunostaining with Ki-67. The Ki-67 labeling index ranged from 
4% to 15% in the study group, and 2% to 13% in the control group (data not shown). There 
was no significance between the study group and the control group. 
DISCUSSION 
Follicular lymphoma is a representative indolent B-cell lymphoma; it grows very slowly and 
most patients show rather long clinical course. Although clinically indolent, these lymphoma 
patients have widespread disease at diagnosis, including peripheral and central (abdominal 
and thoracic) lymphadenopathy and splenomegaly. Histologically, it is characterized by 
nodular proliferation of neoplastic B cells.1–3 
The FDC networks present in the reactive and neoplastic germinal centers (GC) play 
important roles for providing microenviromental conditions to GC B cells: their presence 
facilitates the survival and proliferation of GC lymphocytes.7–12 Moreover, FDCs are important 
to prevent apoptosis of FL cells; this effect is related to the expression of activated markers 
such as CD54 (ICAM-1), CD106 (VCAM-1) and CD40. FDCs in FL express a variable 
spectrum of the differentiation markers, ranging from a pattern similar to reactive follicles with 
expression of the germinal center specific chemokine CXCL13, CD23, CD21 and CD35 to a 
more undifferentiated status with loss of CD23, CD21 and CD35 but still expressing CXCL13. 
Disruption of these patterns suggest related to the progression and transformation of FL.10,13 
In FL lymphoma, structural alterations such as an atypical shape or expansion of the FDC 
networks are frequently detectable both in nodal and extranodal sites.14,15 In the present 
study, we found that the occurrence of the atypical FDC pattern with loss of CD21 FDC 
antigen was significantly related to localized clinical stage. This phenomenon is similar to 
duodenal FL. The duodenal FL usually lack FDC networks and showed localized clinical 
stage,5,6 and this FDC pattern is somewhat similar to the follicular colonization of mucosa-
associated tissue (MALT) lymphomas, in which marginal zone B-cell lymphoma cells infiltrate 
the non-neoplastic GC and destroy FDC networks.6 Therefore we considered duodenal FL 
share some common characteristics with MALT lymphoma.5,6 It could be concluded that loss 
of FDC in neoplastic follicles of nodal FL may show some common features in pathologic 
process with duodenal, and exhibit a similar limited clinical stage. 
Follicular dendritic cells can be detected among the reactive bystander cells of the tumor in 
non-Hodgkin lymphomas. It has been suggested that FDC in FL are newly generated during 
lymphoma expansion, whereas the FDC are considered to represent remnants of the 
germinal center that have been colonized by neoplastic cells in marginal zone lymphoma.14,16 
If the FDC are newly generated in FL, the pre-forming reactive germinal centers for the 
lymphoma neoplastic cells proliferation are needed. Microdissection from two follicles in one 
case for PCR of IgVH genes were illustrated that besides the tumor band being present in all 
lanes, in addition, other bands were apparent, some of which were apparent, some of which 
were shared between microdissections from the same follicle. These findings suggest an 
oligoclonal GC population.17 Similar studies using genealogical trees for the VH and the VL 
gene rearrangements were constructed to analyze the clonal relationship among individual 
cells of distinct follicles of each case. The observation that the neoplastic cells migration 
depend on the follicular microenvironment for their clonal expansion.18 So total or partial lack 
of FDC networks cause a low-functional germinal center to be formed and inefficient co-
stimulation with neoplastic cells. We further compared the three subclassified atypical FDC 
pattern cases with the control group separately. Interestingly, the vanished FDC pattern and 
duodenal FDC pattern cases show a high rate of limited clinical stage (P < 0.05), but there 
was no statistically significant difference in the cases with marginal FDC pattern. This further 
testified our finding that the neoplastic cells expansion prefers a FDC network relative to 
intact and FLs growth exhibits a more progressing process and higher clinical stage. 
Undifferentiated stroma in FL may result from failure to recruit FDCs, or to provide signals 
for complete FDC maturation, or as a result of a progressive loss of FDC differentiation in 
preformed GCs that have been colonized by lymphoma.15 Although the vanished FDC pattern 
cases showed a high rate of limited clinical stage in contrast to typical cases, 11 of 17 cases 
(65%) still showed a more aggressive clinical stage. Previous observation by Dogan et al.19 
revealed that the interfollicular tumor component in FL cases usually has a much lower mitotic 
activity than the follicular component. This suggests that neoplastic cells may be aggregating 
in interfollicular areas in contrast to diffuse growth forming descrete areas, indicating that 
extrafollicular proliferation was occurring.10,20,21 In our study, limited stage cases of the 
vanished group showed a partial nodularity pattern but a lack of FDC differentiation. By 
contrast, a dominantly diffuse pattern was found in the rest of the vanished group, in which it 
showed a progressive clinical stage (data not shown). The changes of FDC differentiation in 
the former group may be caused by antigen loss, followed by loss of FDC maturation. In the 
latter group, lymphoma growth may have shifted to a FDC-free growth pattern. Further study 
should be established on this view. 
There was no significant correlation between the FDC pattern and the Ki-67 labeling index, 
which may be due to the low Ki-67 labeling index in each group with histological grade 1. 
Therefore, FDC may relate to the migration of lymphoma cells rather than their proliferation 
activity. 
In conclusion, our data revealed the atypical FDC pattern of FLs, which was found in 11% 
of examined FLs, significantly showed localized clinical stage (I or II) more than typical FDC 
pattern of FLs and the FDC pattern suggest that related to the spread of the disease. 
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Figure 1    Immunohistochemical stain of CD21 in nodal follicular lymphomas. (a) Typical pattern of 
follicular dendritic cell (FDC) expressing CD21. FDC networks are densely found in neoplastic follicle 
areas; (b) Vanished pattern. FDC networks were absent in most of the neoplastic follicle areas; (c) 
Duodenal pattern. FDC networks were distributed in the periphery of the neoplastic follicles areas; (d) 
marginal pattern. FDC networks occupied more than half of the neoplastic follicle areas, but were 
absent in the center of the neoplastic follicle areas. 
Table 1    Clinicopathologic data of nodal follicular lymphomas 
P-value was determined by Fisher’s exact test. 
FDC, follicular dendritic cell; NOS, not other specific. 
Table 2    Number (%) of patients with clinical stages according to follicular dendritic cell (FDC) network features in the 
neoplastic follicle areas 
P-value was determined by Fisher’s exact test. 
The difference of clinical stages between the study group and the control group was statistically significant (P < 0.05).
Control group (typical 
FDC pattern)
Study group (atypical 
FDC pattern)
P-valuen = 58 (%) n = 27 (%)
Average age (range) 58.1 (32–85) 59.0 (39–84)
Gender (M/F) 34/24 16/11
Histological grade (n = 85)
1 35 (60%) 16 (59%) 0.999
2 10 (17%) 9 (33%) 0.285
3A 6 (10%) 2 (7%) 0.999
NOS 5 (9%) 0 0.316
With diffuse areas 2 (3%) 0 0.999
Control group 
(typical FDC 
pattern)
Study group 
(atypical FDC 
pattern)
Cases with 
vanished pattern 
of FDC network
Cases with 
duodenal pattern 
of FDC network
Cases with 
marginal pattern 
of FDC network
n = 58 (%) n = 27 (%) n = 17 (%) n = 3 (%) n = 7 (%)
Stage I 0 (0) 4 (15) 3 (18) 1 0
Stage II 6 (10) 6 (22) 3 (18) 1 2
Localized disease 
(Stage I/II) 6 (10) 10 (37) 6 (35) 2 2
Stage III 26 (45) 11 (41) 7 (41) 1 3
Stage IV 26 (45) 6 (22) 4 (24) 0 2
Systemic disease 
(Stage III/IV) 52 (90) 17 (63) 11 (65) 1 5
P-value 0.0062 0.023 0.043 0.203
